Contents
Overview
RANIBIZUMAB is a Schedule H drug.Ranibizumab is made from a human antibody fragment. It works by keeping new blood vessels from forming under the retina (a sensory membrane that lines the inside of the eye). In people with certain types of eye disorders, new blood vessels grow under the retina where they leak blood and fluid. Ranibizumab ophthalmic (for the eyes) is used to treat the "wet form" of age-related macular degeneration. Ranibizumab is also used to treat swelling in the retina caused by diabetes or a blockage in the blood vessels.
Usage
RANIBIZUMAB is generally used to treat: Macular DegenerationFrequently Asked Questions
Q: Is it safe on my liver?A: Check with your Doctor first
Q: Is it safe on my kidney?
A: Check with your Doctor first
Q: Can I take it with alcohol?
A: Not Safe
Q: Is it safe for children?
A: Ask your doctor
How Do I Take It?
Route of Administration: Ophthalmic (Eye)Precautions
Caution should be exercised in patients withCommon Side-Effects
RANIBIZUMAB : Dizziness, Eyes Pain, Head Headache, Irregular Heartbeat, Nasal Congestion, Runny Nose, Throat Soreness, Weight Loss (unintentional)Serious Side-Effects
RANIBIZUMAB : Stroke, Heart Attack, BLOOD CLOT, Sudden Numbness Or Weakness On One Side Of Body, Slurred Speech, ConfusionRare Side-Effects
RANIBIZUMAB : Skin Rash, Difficulty Breathing, Face Swelling, Body ItchingDisease Interactions
RANIBIZUMAB can interfere with: Uveitis, Optic Neuritis, GlaucomaTechnical Classification
RANIBIZUMAB is categorized as: ANTI-ANGIOGENIC OPHTHALMIC AGENTS / OPHTHALMIC PREPARATIONS / TOPICAL AGENTSStorage Conditions
Room Temperature (Between 15 To 25 C)Available Alternatives
Common Drugs with RANIBIZUMAB as Ingredient
LUCENTIS 0.5MG INJ | RANIBIZUMAB 0.5 MG |